Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2, Single-Arm, Open-Label, Multi-Center Trial of Second-Line Panitumumab Monotherapy in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT00446446 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00446446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00446446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2, Single-Arm, Open-Label, Multi-Center Trial of Second-Line Panitumumab Monotherapy in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
October 30, 2007
Completion date
November 29, 2017
Enrollment
52 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, carcinoma, head and neck cancer, metastases, metastatic cancer, metastatic or recurrent squamous cell carcinoma of head and neck, oncology, squamous cell carcinoma, tumors